@article{mbs:/content/journal/jmm/10.1099/jmm.0.000801, author = "Mathy, Vincent and Grohs, Patrick and Compain, Fabrice", title = "In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis", journal= "Journal of Medical Microbiology", year = "2018", volume = "67", number = "9", pages = "1217-1220", doi = "https://doi.org/10.1099/jmm.0.000801", url = "https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.000801", publisher = "Microbiology Society", issn = "1473-5644", type = "Journal Article", keywords = "β-lactam", keywords = "avibactam", keywords = "Stenotrophomonas", keywords = "Achromobacter", keywords = "Pseudomonas", keywords = "cystic fibrosis", abstract = "The in vitro activity of anti-pseudomonal β-lactams in combination with avibactam was evaluated against 54 multidrug-resistant non-fermenting Gram-negative bacilli isolated from cystic fibrosis patients. Avibactam increased and/or restored the antibacterial activities of ceftazidime and aztreonam against Pseudomonas aeruginosa and Stenotrophomonas maltophilia, respectively. No β-lactam–avibactam combination was active against Achromobacter xylosoxidans.", }